Are you excited about RNA therapeutics, protein biologics, or the future of genomic medicine? Join us for a virtual fireside chat with Dr. Igor Splawski, chief scientific officer at Yarrow Biotechnology, Inc., a company incubated by RTW Investments.
In this insightful discussion, Dr. Splawski will delve into his distinguished career in drug development, including his pivotal role as chief scientific officer at CureVac, where he led a team of 150 scientists pioneering mRNA technologies and therapeutics for infectious diseases, cancer, and rare diseases. He will also share his experiences from 15 years at Novartis Institutes for BioMedical Research (NIBR), where he worked with a team of over 100 scientists advancing antibody and protein therapeutics.